Suppr超能文献

耐药性的分子机制:突变对抑制剂与HIV-1蛋白酶结合影响的自由能计算

Molecular mechanisms of resistance: free energy calculations of mutation effects on inhibitor binding to HIV-1 protease.

作者信息

Rick S W, Topol I A, Erickson J W, Burt S K

机构信息

Frederick Biomedical Supercomputing Center, SAIC-Frederick, NCI-Frederick Cancer Research and Development Center, Maryland 27102, USA.

出版信息

Protein Sci. 1998 Aug;7(8):1750-6. doi: 10.1002/pro.5560070809.

Abstract

The changes in the inhibitor binding constants due to the mutation of isoleucine to valine at position 84 of HIV-1 protease are calculated using molecular dynamics simulations. The calculations are done for three potent inhibitors--KNI-272, L-735,524 (indinavir or MK-639), and Ro 31-8959 (saquinavir). The calculations agree with the experimental data both in terms of an overall trend and in the magnitude of the resulting free energy change. HIV-1 protease is a homodimer, so each mutation causes two changes in the enzyme. The decrease in the binding free energy from each mutated side chain differs among the three inhibitors and correlates well with the size of the cavities induced in the protein interior near the mutated residue. The cavities are created as a result of a mutation to a smaller side chain, but the cavities are less than would be predicted from the wild-type structures, indicating that there is significant relaxation to partially fill the cavities.

摘要

利用分子动力学模拟计算了HIV-1蛋白酶84位异亮氨酸突变为缬氨酸导致的抑制剂结合常数变化。对三种强效抑制剂——KNI-272、L-735,524(茚地那韦或MK-639)和Ro 31-8959(沙奎那韦)进行了计算。计算结果在总体趋势和产生的自由能变化幅度方面均与实验数据相符。HIV-1蛋白酶是一种同二聚体,因此每次突变都会在酶中引起两处变化。三种抑制剂中,每个突变侧链导致的结合自由能降低情况不同,且与突变残基附近蛋白质内部诱导产生的空穴大小密切相关。空穴是由突变为较小侧链导致的,但空穴比野生型结构预测的要小,这表明存在显著的松弛以部分填充空穴。

相似文献

引用本文的文献

本文引用的文献

2
Angströms and calories.埃(长度单位)和卡路里。
Structure. 1997 Apr 15;5(4):473-9. doi: 10.1016/s0969-2126(97)00204-9.
8
Structure-based inhibitors of HIV-1 protease.基于结构的HIV-1蛋白酶抑制剂。
Annu Rev Biochem. 1993;62:543-85. doi: 10.1146/annurev.bi.62.070193.002551.
9
Structural and genetic analysis of protein stability.蛋白质稳定性的结构与遗传分析
Annu Rev Biochem. 1993;62:139-60. doi: 10.1146/annurev.bi.62.070193.001035.
10
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4096-100. doi: 10.1073/pnas.91.9.4096.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验